| Bioactivity | RAD51 Inhibitor B02 (B02) is an inhibitor of human RAD51 with an IC50 of 27.4 μM. | ||||||||||||
| Invitro | RAD51 Inhibitor B02 specifically inhibits human RAD51 (IC50=27.4 μM), but not its E. coli homologue RecA (IC50>250 μM)[1]. The combination of B02 with cisplatin has the strongest killing effect on the human breast cancer cells MDA-MB-231[2]. | ||||||||||||
| Name | RAD51 Inhibitor B02 | ||||||||||||
| CAS | 1290541-46-6 | ||||||||||||
| Formula | C22H17N3O | ||||||||||||
| Molar Mass | 339.39 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|